UPDATE ON MANAGEMENT OF HCV- GENOTYPES 2 & 3

EPIDEMOLOGY: Global Challenge – global impact ,130-170 million chronically infected approximately 2-2.5% of world’s total population. REGINOL DIFFERENCES: Highest prevalence rates – developing poor countries in Africa & Asia e.g PAKISTAN, INDIA, CHINA. Low prevalence rate in developed countries. HCV –    Treatment Goals: To reduce virus related complications & achieve SVR, SVR – clearance of […]

read more
On March 30th, 2016, posted in: Blog by